The quakingviable mutation affects qkI mRNA expression specifically in myelin-producing cells of the nervous system

被引:28
作者
Lu, ZF [1 ]
Zhang, YY [1 ]
Ku, L [1 ]
Wang, HP [1 ]
Ahmadian, A [1 ]
Feng, Y [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
关键词
D O I
10.1093/nar/gkg635
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genetic lesion in the quakingviable (qk(v)) mutant mice is a deletion 5' to the qkI gene, resulting in severe hypomyelination. qkI produces several QKI protein isoforms via alternative splicing of the C-terminal coding exons. In the qk(v)/qk(v) brain, immunostaining of QKI proteins is diminished in an isoform-differential manner with undefined mechanisms. We examined the expression of QKI protein isoforms and qkI mRNA isoforms in the qk(v)/qk(v) mutants and the non-phenotypic wt/qk(v) littermates. Our results indicated significant reduction of all qkI mRNA isoforms in the central and peripheral nervous system during active myelination without detectable post-transcriptional abnormalities. In the early stage of myelin development, qkI mRNAs are differentially reduced, which appeared to be responsible for the reduction of the corresponding QKI protein isoforms. The reduced qkI expression was a specific consequence of the qk(v) lesion, not observed in other hypomyelination mutants. Further more, no abnormal qkI expression was found in testis, heart and astroglia of the qk(v)/qk(v) mice, suggesting that the reduction of qkI mRNAs occurred specifically in myelin-producing cells of the nervous system. These observations suggest that diminished qkI expression results from deletion of an enhancer that promotes qkI transcription specifically in myelinating glia during active myelinogenesis.
引用
收藏
页码:4616 / 4624
页数:9
相关论文
共 23 条
[1]   FMR1 PROTEIN - CONSERVED RNP FAMILY DOMAINS AND SELECTIVE RNA-BINDING [J].
ASHLEY, CT ;
WILKINSON, KD ;
REINES, D ;
WARREN, ST .
SCIENCE, 1993, 262 (5133) :563-566
[2]   HYPOMYELINATED MUTANT MICE - DESCRIPTION OF JPMSD AND COMPARISON WITH JP AND QK ON THEIR PRESENT GENETIC BACKGROUNDS [J].
BILLINGSGAGLIARDI, S ;
ADCOCK, LH ;
WOLF, MK .
BRAIN RESEARCH, 1980, 194 (02) :325-338
[3]   CELLULAR AND MOLECULAR ASPECTS OF MYELIN PROTEIN GENE-EXPRESSION [J].
CAMPAGNONI, AT ;
MACKLIN, WB .
MOLECULAR NEUROBIOLOGY, 1988, 2 (01) :41-89
[4]   The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins [J].
Ebersole, TA ;
Chen, Q ;
Justice, MJ ;
Artzt, K .
NATURE GENETICS, 1996, 12 (03) :260-265
[5]  
Feng Y, 1997, J NEUROSCI, V17, P1539
[6]   FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association [J].
Feng, Y ;
Absher, D ;
Eberhart, DE ;
Brown, V ;
Malter, HE ;
Warren, ST .
MOLECULAR CELL, 1997, 1 (01) :109-118
[7]  
Fruttiger M, 1999, DEVELOPMENT, V126, P457
[8]   Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease [J].
Gow, A ;
Southwood, CM ;
Lazzarini, RA .
JOURNAL OF CELL BIOLOGY, 1998, 140 (04) :925-934
[9]  
Hardy RJ, 1998, J NEUROSCI RES, V51, P417, DOI 10.1002/(SICI)1097-4547(19980215)51:4<417::AID-JNR1>3.0.CO
[10]  
2-F